Wednesday, November 28, 2012

Increased off label antipsychotic drug use found among children

Non FDA approved increased off label antipsychotic drug use found among children
ScienceDaily (Sep. 10, 2012) — A national study conducted by researchers at The Children's Hospital of Philadelphia (CHOP) shows increased use of powerful antipsychotic drugs to treat publicly insured children over the last decade. The study, published September 10 in the journal Health Services Research, found a 62 percent increase in the number of Medicaid-enrolled children ages 3 to 18 taking antipsychotics, reaching a total of 354,000 children by 2007.  Read more:
Affordable Health Care will operate like much like Medicare approved insurance, which lack sufficient and timely oversight and enforcement by Medicare.  Approved insurance companies, like Humana, are allowed to
  • commit fraud, 
  • change contracted services, 
  • threaten users, and 
  • drop insured at anytime, 
despite the fact that insurance users cannot change insurance companies during the contract period.

Without oversight by HHS, United States children are at risk from FDA non approved off-label (generic, substitutes) made by HHS approved insurers.  Save a child's life by sharing this important notice.

No comments:

Post a Comment

Only members can comment on Children's EPA blog. Please subscribe and become a member of Children's EPA

Note: Only a member of this blog may post a comment.